During this exclusive on-the-record briefing for reporters, Robert M. Califf, M.D., Commissioner of Food and Drugs for the U.S. Food and Drug Administration, participated in a fireside chat with Sarah J. Dash, President and CEO of the Alliance for Health Policy, and respond to audience questions.
During this exclusive on-the-record briefing for reporters, Admiral Rachel L. Levine, M.D., Assistant Secretary for Health at the U.S. Department of Health and Human Services, provided some opening remarks and responded to audience questions.
Dr. Meena Seshamani, M.D., Ph.D. director of the Center for Medicare and deputy administrator of the Centers for Medicare and Medicaid Services at the U.S. Department of Health and Human Services, will provide some opening remarks and respond to audience questions.
In this session exclusively for journalists, expert panelists explored the tension between the affordability of prescription drugs and the need to preserve advances in biomedical innovation.
Elizabeth Fowler, J.D., Ph.D., director of the Center for Medicare and Medicaid Innovation (CMMI) and deputy administrator of the Centers for Medicare and Medicaid Services at the U.S. Department of Health and Human Services, provided some opening remarks and responded to audience questions.
Dr. Stephen Hahn addressed the role of the U.S. Food and Drug Administration in the COVID-19 response and best practices and lessons learned from the emergency response to date.
This discussion focused on measures industry stakeholders have taken for safe COVID-19 vaccine deployment and the immediate steps these stakeholders will take in the first 48 hours after the Emergency Use Authorization was approved.
Dr. Anand Shah provided opening remarks and answered questions about the U.S. Food and Drug Administration’s role in the national COVID-19 response.
During this on-the-record briefing for reporters, Dr. Anthony S. Fauci, Director, National Institute of Allergy and Infectious Disease at the National Institutes of Health provided insight into the status of the COVID-19 pandemic. Dr. Fauci discussed the status of spread of the virus in the United States and highlighted progress toward successful treatments and vaccines.
During this teleconference, experts discussed the prescription drug supply chain, the progression of a COVID-19 vaccine, and the related infrastructure needs.
As the coronavirus spreads, health systems across the country are gearing up for an influx of patients. States play a central role in the organization of health care and public health infrastructure, but a range of resources and legislative decisions, as well as different demographics, can lead to divergent outcomes across states.
As the coronavirus spreads, health care systems across the country are gearing up for an influx of patients. But how do we ensure that we’re protecting the health of the health care workers on the front lines of the outbreak?
During this on-the-record briefing for reporters, Admiral Brett P. Giroir, M.D., Assistant Secretary for Health at the U.S. Department of Health and Human Services, provided opening remarks and responded to questions from reporters.
During this on-the-record briefing for reporters, Dr. Mona Siddiqui, Chief Data Officer in the Office of the Chief Technology Officer at the U.S. Department of Health and Human Services, will provide opening remarks and respond to questions from reporters.
During this on-the-record briefing for reporters, Joe Grogan, Assistant to the President and Director of the Domestic Policy Council provided opening remarks and responded to questions from reporters. The question and answer period was moderated by William Pierce, Senior Director, APCO Worldwide.
During this on-the-record briefing for reporters, Anna Greenberg, managing partner at Greenberg Quinlan Rosner Research, and Dan Judy, research analyst for North Star Opinion Research, will discuss how public opinion on health care has informed campaign platforms and impacted voter attitudes.
Joe Grogan, J.D., associate director of Health Programs at the Office of Management and Budget will speak at the reporter breakfast on Thursday, September 20, 2018. This event is for reporters only.
This exclusive reporter briefing featured FDA Commissioner Scott Gottlieb, M.D., followed by a panel of industry leaders and stakeholders responding to new drug pricing guidance.
The on-the-record, reporter-only briefing will begin with remarks from Rep. DeGette, followed by a moderated question and answer session.